Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Consortium kiest nieuwe aanpak in ontwikkeling vaccins tegen parasitaire wormen
jan 2025 | Parasitaire infecties, Vaccinatie